Casey Means’ Confirmation Hearing Raises Questions About Public Health Approach

The confirmation hearing for Dr. Casey Means, President Donald Trump’s nominee for U.S. Surgeon general, has sparked debate over the administration’s approach to public health messaging, particularly regarding vaccinations. Means’s responses during the hearing, and her broader philosophy on addressing chronic disease, contrast with traditional public health strategies and have drawn scrutiny from both sides of the political aisle.

A Shift Towards “Shared Clinical Decision-Making”

During her Senate health committee hearing, Means declined to directly state whether she would encourage parents to vaccinate their children against measles, despite ongoing outbreaks across the U.S. She emphasized the importance of individual doctor-patient conversations, stating, “I am not an individual’s doctor,” and that individuals should discuss medications with their physicians.

This stance aligns with a broader shift within the Trump administration towards “shared clinical decision-making” regarding vaccinations. In October 2025, the Centers for Disease Control and Prevention (CDC) announced it would no longer universally recommend COVID-19 boosters, instead advocating for detailed conversations between doctors and patients about the risks and benefits. This approach was later extended to vaccines against rotavirus, influenza, meningococcal disease, and hepatitis A and B in January 2026.

Addressing Root Causes vs. “Reactive Sick Care”

Means has articulated a vision for addressing the underlying causes of chronic disease, rather than focusing on “reactive sick care.” This message resonates with Health Secretary Robert F. Kennedy Jr.’s “Make America Healthy Again” movement and has garnered some bipartisan support. However, her lack of government experience and the fact that her medical license is currently inactive have raised concerns among some senators.

The Debate Over Informed Consent and Shared Decision-Making

The administration’s emphasis on shared decision-making has sparked debate about its distinction from informed consent. While informed consent involves ensuring patients understand the risks and benefits of a medical intervention, shared decision-making is presented as appropriate for scenarios where the trade-offs are more nuanced. Critics argue that routine immunizations, such as the hepatitis B vaccine, do not fall into this category, given their proven effectiveness and safety.

Concerns About Undermining Public Health Trust

Some observers have expressed concern that the administration’s approach undermines public health trust by questioning established medical advice. Despite advocating for patients to consult their doctors, some officials within the administration, including FDA Commissioner Marty Makary, have previously criticized the medical establishment.

The debate surrounding Casey Means’s confirmation highlights a fundamental tension between individual autonomy and the collective benefits of public health interventions. Her confirmation, and the direction she would steer the Office of the Surgeon General, remain uncertain.